Get the Stockscreener App
5.58
7.46%
-0.45
After Hours:
5.41
-0.17
-3.05%
Universe Pharmaceuticals Inc stock is traded at $5.58, with a volume of 43,012.
It is down -7.46% in the last 24 hours and up +34.78% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$6.03
Open:
$5.74
24h Volume:
43,012
Relative Volume:
0.09
Market Cap:
$3.12M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-3.2824
EPS:
-1.7
Net Cash Flow:
$1.08M
1W Performance:
+13.65%
1M Performance:
+34.78%
6M Performance:
-92.21%
1Y Performance:
-99.64%
1-Day Range:
$5.40
$5.95
1-Week Range:
$4.80
$6.42
52-Week Range:
$2.51
$2,592.00
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
5.58 | 2.77M | 32.31M | -6.16M | 1.08M | -1.70 |
|
HLN
Haleon Plc Adr
|
11.10 | 46.84B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
161.44 | 68.97B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.90 | 3.33M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.32 | 42.83B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.55 | 19.37B | 16.54B | -1.64B | 749.00M | -1.45 |
Universe Pharmaceuticals Inc Stock (UPC) Latest News
US-China Trade Breakthrough Sparks Market Optimism, Says DeVere CEO - Universe News Network
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 77% - simplywall.st
Improved Revenues Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Stock's 77% Jump Looks Justified - simplywall.st
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Pepper Money Expands Wellbeing Support With Largest-Ever Broker Retreat Series - Universe News Network
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Universe Pharmaceuticals Reports Full Year 2024 Earnings - Yahoo Finance
Universe Pharmaceuticals INC (UPC) Stock: A Year of Highs and Lows - investchronicle.com
Bitfarms Ltd [BITF] Revenue clocked in at $192.88 million, down -31.54% YTD: What’s Next? - dbtnews.com
Universe Pharmaceuticals INC [UPC] Is Currently 41.67 below its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
Power & Digital Infrastructure Acquisition (OTCMKTS:XPDIU) Stock Price Up 1.8% – Should You Buy? - Defense World
Universe Pharmaceuticals (NYSE:UPC) Shares Up 10.5% – Here’s Why - Defense World
Universe Pharmaceuticals INC (UPC) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Pre-market Movers: RGC, SYRS, ADTX, ATXI... - RTTNews
UPC’s Stock Dilemma: Universe Pharmaceuticals INC’s Market Performance and Outlook - investchronicle.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners - 24/7 Wall St.
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Universe Pharmaceuticals stock plunges to 52-week low of $3.20 - Investing.com
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
Pre-market Movers: TNON, POAI, MURA, BSGM... - RTTNews
Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - markets.businessinsider.com
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 By Investing.com - Investing.com Australia
Universe Pharmaceuticals stock plunges to 52-week low of $0.08 - Investing.com
Universe Pharmaceuticals Announces Share Consolidation - TipRanks
Universe Pharmaceuticals Plans To Effect Share ConsolidationQuick Facts - Nasdaq
Universe Pharmaceuticals INC Announces Share Consolidation Effective March 24, 2025 - Nasdaq
NewtekOne, Inc. Closes Private Offering of Senior Unsecured Notes - The Manila Times
Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewswire
Major Shake-up: Universe Pharmaceuticals Announces 40:1 Share ConsolidationWhat It Means For Investors - StockTitan
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals stock plunges to 52-week low of $0.1 - Investing.com India
Universe Pharmaceuticals (NYSE:UPC) Trading Down 4.3% – What’s Next? - Defense World
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
Universe Pharmaceuticals Approves Share Consolidation at Extraordinary Meeting - TipRanks
UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN
Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com India
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times
Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks
Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.50%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):